Medications

Price rise for anti-allergy EpiPen sparks furor

A five-fold price hike for EpiPen, which allergy sufferers use to counteract life-threatening reactions, has made Mylan the newest drugmaker to come under attack in the United States for profiteering.

Health

Drowsy driving causes 1 in 5 fatal crashes: report

(HealthDay)—Nearly 84 million sleep-deprived Americans take to the roads every day. And, drowsy driving was a factor in crashes that claimed about 5,000 lives last year, a new report shows.

Diseases, Conditions, Syndromes

Study discovers molecular pathways for the development of mucormycosis

Research published today in the journal, Nature Communications, provides new insights into the evolution of Mucorales fungi, which cause a fatal infection in ever-increasing segments of patient population, and several molecular ...

Diseases, Conditions, Syndromes

Breakthrough could help sufferers of fatal lung disease

Pioneering research conducted by the University of Sheffield is paving the way for new treatments which could benefit patients suffering from the fatal lung disease pulmonary arterial hypertension (PAH).

page 7 from 23